Home/Filings/4/0001179110-05-014576
4//SEC Filing

GENAISSANCE PHARMACEUTICALS INC 4

Accession 0001179110-05-014576

CIK 0001110009operating

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 4:27 PM ET

Size

5.6 KB

Accession

0001179110-05-014576

Insider Transaction Report

Form 4
Period: 2005-06-30
Transactions
  • Award

    Common Stock

    2005-06-30+9,26322,363 total
Holdings
  • Common Stock

    (indirect: Common shares owned by Merifin Capital N.V., of which Christopher Wright is an executive director.)
    570,507

Issuer

GENAISSANCE PHARMACEUTICALS INC

CIK 0001110009

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001110009

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:27 PM ET
Size
5.6 KB